2026. Antitumor and Antimetastatic Activity of a Novel Pyrimidin-4-one Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study. Voprosy onkologii. 72, 4 (Sep. 2026), 2630. DOI:https://doi.org/10.37469/0507-3758-2026-72-4-2630.